top of page
tokers-guide-find-the-best-weed-in-dc-lo
NEW 1 to 1 photo editing 122024 (17).png
The day's cannabis headlines include a hemp dispute that may upend federal funding legislation, a USPS mailing ruling, and state and local policy moves.

Hemp Fight Could Complicate Federal Funding Bills

Nov 19, 2026

Source:

Tom Angell

Marijuana Moment

A busy day in cannabis policy begins with the hemp debate, which could upend federal funding legislation. Spending bills are supposed to be about keeping the government running, but hemp provisions have a way of turning them into a battleground, and that dynamic is back in play. How lawmakers handle hemp could affect whether the broader funding package moves smoothly, and it matters to every business that sells hemp-derived products.

Another item with national reach involves the U.S. Postal Service, which has described medical marijuana as nonmailable. For patients and businesses hoping to ship cannabis products legally, that position is a reminder that federal law still governs the mail even in states with medical programs. Any restriction on shipping can limit how patients receive products and how companies move goods.

There is also news from the states. A new governor in Wisconsin is talking about marijuana plans, a notable signal in a state that has resisted legalization even as its neighbors have moved ahead. In Oklahoma, a bill is in play that connects medical cannabis with gun rights, a topic that sits at the intersection of state medical programs and federal firearms law, where patients have often run into conflicts.

Finally, there is movement on marijuana policy in Houston, where local officials are working on how cannabis enforcement is handled in the city.

Taken together, the stories show how cannabis policy now advances on several fronts at once: Congress, federal agencies, state capitals, and city halls. For consumers and operators in the DC, Maryland, and Virginia area, the hemp fight and the mailing question in particular could have real consequences, so they're worth keeping an eye on as the funding debate unfolds.

Recent Reviews

bottom of page